These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 18674808)

  • 1. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
    Nemani D; Mitra N; Guo M; Lin L
    Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma.
    Clayton Smith D; Kenneth Macdonald O; Gaffney DK
    Radiother Oncol; 2008 Aug; 88(2):227-32. PubMed ID: 18160157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiation therapy in stage III node-positive uterine cancer.
    Schmid S; Hsu IC; Hu JM; Sherman AE; Osann K; Kapp DS; Chan JK
    Gynecol Oncol; 2009 Nov; 115(2):239-43. PubMed ID: 19679341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma.
    Parthasarathy A; Cheung MK; Osann K; Husain A; Teng NN; Berek JS; Kapp DS; Chan JK
    Gynecol Oncol; 2006 Dec; 103(3):1095-9. PubMed ID: 16889821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of adjuvant radiation in uterine sarcomas.
    Sampath S; Schultheiss TE; Ryu JK; Wong JY
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):728-34. PubMed ID: 19700247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?
    Crosby MA; Tward JD; Szabo A; Lee CM; Gaffney DK
    Am J Clin Oncol; 2010 Aug; 33(4):364-9. PubMed ID: 20689365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer.
    Parthasarathy A; Kapp DS; Cheung MK; Shin JY; Osann K; Chan JK
    Obstet Gynecol; 2007 Dec; 110(6):1237-43. PubMed ID: 18055715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma.
    Wright JD; Seshan VE; Shah M; Schiff PB; Burke WM; Cohen CJ; Herzog TJ
    Am J Obstet Gynecol; 2008 Nov; 199(5):536.e1-8. PubMed ID: 18511017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphadenectomy for patients with cervical cancer: is it of value?
    Rossi PJ; Horowitz IR; Johnstone PA; Jani AB
    J Surg Oncol; 2009 Oct; 100(5):404-6. PubMed ID: 19760670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
    Konety BR; Joslyn SA
    J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of axillary lymphadenectomy on breast carcinoma survival.
    Joslyn SA; Konety BR
    Breast Cancer Res Treat; 2005 May; 91(1):11-8. PubMed ID: 15868427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node density is a significant predictor of outcome in patients with oral cancer.
    Gil Z; Carlson DL; Boyle JO; Kraus DH; Shah JP; Shaha AR; Singh B; Wong RJ; Patel SG
    Cancer; 2009 Dec; 115(24):5700-10. PubMed ID: 19691095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
    Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC
    Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.
    Coburn NG; Swallow CJ; Kiss A; Law C
    Cancer; 2006 Nov; 107(9):2143-51. PubMed ID: 17001662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
    Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
    Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis.
    Rauh-Hain JA; Starbuck KD; Meyer LA; Clemmer J; Schorge JO; Lu KH; Del Carmen MG
    Gynecol Oncol; 2015 Oct; 139(1):84-9. PubMed ID: 26307402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.